Vaxcyte
PCVX
#1749
Rank
C$13.73 B
Marketcap
$106.65
Share price
-2.21%
Change (1 day)
14.51%
Change (1 year)

Revenue for Vaxcyte (PCVX)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vaxcyte from 2019 to 2024

2020202120222023$0M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA